Details for Patent: 6,020,358
✉ Email this page to a colleague
Summary for Patent: 6,020,358
Title: | Substituted phenethylsulfones and method of reducing TNF.alpha. levels |
Abstract: | Phenethylsulfones substituted in the position .alpha. to the phenyl group with a 1-oxoisoindoline or 1,3-dioxoisoindoline group reduce the levels of TNF.alpha. in a mammal. Typical embodiments are 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-aminoisoindoline- 1,3-dione and 2-[1-(3-cyclopentyloxy-4-methoxyphenyl)-2-methylsulfonylethyl]isoindoline- 1,3-dione. |
Inventor(s): | Muller; George W. (Bridgewater, NJ), Man; Hon-Wah (Neshanic Station, NJ) |
Assignee: | Celgene Corporation (Warren, NJ) |
Application Number: | 09/183,049 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent 6,020,358
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,020,358
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 350033 | ⤷ Sign Up | |||
Austria | 471718 | ⤷ Sign Up | |||
Australia | 1447200 | ⤷ Sign Up | |||
Australia | 2003203681 | ⤷ Sign Up | |||
Australia | 756308 | ⤷ Sign Up | |||
Brazil | 9915201 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |